Multidrug‐Resistant Bacteria: Their Mechanism of Action and Prophylaxis
Open accessThe DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Abstract
In the present scenario, resistance to antibiotics is one of the crucial issues related to public health. Earlier, such resistance to antibiotics was limited to nosocomial infections, but it has now become a common phenomenon. Several factors, like extensive development, overexploitation of antibiotics, excessive application of broad‐spectrum drugs, and a shortage of target‐oriented antimicrobial drugs, could be attributed to this condition. Nowadays, there is a rise in the occurrence of these drug‐resistant pathogens due to the availability of a small number of effective antimicrobial agents. It has been estimated that if new novel drugs are not discovered or formulated, there would be no effective antibiotic available to treat these deadly resistant pathogens by 2050. For this reason, we have to look for the formulation of some new novel drugs or other options or substitutes to treat such multidrug‐resistant microorganisms (MDR). The current review focuses on the evolution of the most common multidrug‐resistant bacteria and discusses how these bacteria escape the effects of targeted antibiotics and become multidrug resistant. In addition, we also discuss some alternative mechanisms to prevent their infection as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877 · cited 2×
“If the patient was in a hospital under critical care for 48 hours or more; within 90 days of the infection; admitted to the hospital or persistent care for an extended period of time; received chemotherapy; intravenous antibiotic treatment; or wound care in the previous month of the existing illness [11], this is cons…”
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784 · cited 1×
“encoding genetic enzyme degrades with antibiotics, for example, β-lactamase which includes penicillinase only degrading penicillin, cephalosporinases deactivate cephalosporins and aminopenicillins, and expanded beta-lactamases, which play an important role in digesting all β-lactam, but carbapenemase and carbapenem di…”
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · cited 1×
“It causes several deadly diseases, including infective endocarditis, skin, respiratory tract, and soft tissue infections, and infections of pleuro-pulmonary-related devices [65, 66].”
Silhavy, T. J., Kahne, D., & Walker, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000414 · Cited by 3,798 · cited 3×
“…difference in the cell wall composition of Gram-positive and Gram-negative bacteria, as Gram-positive bacteria possess a thick layer of peptidoglycan over the cytoplasmic membrane that provides protection against adverse environmental conditions, and Gram-negative bacteria lack the LPS layer [53].”
Preparation of aqueous magnetic liquids in alkaline and acidic media
Massart, R. (1981) · IEEE Transactions on Magnetics · doi:10.1109/tmag.1981.1061188 · Cited by 2,817 · cited 1×
“Glutaraldehyde [118] was used to establish a relationship between MNPs and CSA-13.”
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718 · cited 1×
“aureus secretes a plasmidmediated penicillinase, which breaks the β-lactam ring of penicillin, which is required for its antimicrobial activity [67].”
Enhanced bioactivity of ZnO nanoparticles—an antimicrobial study
Padmavathy, N., & Vijayaraghavan, R. (2008) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/9/3/035004 · Cited by 1,680 · cited 1×
“[100 – 106].”
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Characterisation of copper oxide nanoparticles for antimicrobial applications
Ren, G., Hu, D., Cheng, E. W. C., Vargas-Reus, M. A., Reip, P., & Allaker, R. P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.004 · Cited by 1,604
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445 · cited 1×
“Because bacterial biofilms enable the conjugation of plasmids containing antibiotic genes and the biofilm matrix protects bacterial cells in lower films from antibiotics, assertions that bacterial biofilms are extremely tolerant and resistant to antibiotics [120] have been made.”
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282 · cited 1×
“Resistance to quinolones develops due to the mutations occurring in the subunits of these two enzymes (grIA/grIB and gyrA/gyrB) [60, 61]”
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Edris, A. E. (2007) · Phytotherapy Research · doi:10.1002/ptr.2072 · Cited by 1,261 · cited 1×
“The loss of integrity and cellular content caused by the combination of essential oils and lipids leads to cell death [129].”
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250 · cited 3×
“In another study in China, more troublesome results were obtained when out of 32 individuals su ff ering from community-acquired pneumonia caused by A. baumannii , and 3 and 6 isolates were nonsusceptible to meropenem and imipenem, respectively [41].”
InfluentialThe specificity-conferring code of adenylation domains in nonribosomal peptide synthetases
Stachelhaus, T., Mootz, H. D., & Marahiel, M. A. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80082-9 · Cited by 1,237 · cited 1×
“Bioinformatics tools like NRPS Predictor 2, 122, Minowal 123, and PRISM 121 [154] may be used to identify and study possible BGCs from stored genomic sequences.”
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149 · cited 1×
“Resistance develops through the attainment of certain modifying enzymes like phophotransferases, nucleotidyltransferases, acetyltransferases, or through mutation and efflux mechanisms [62]”
Cox, S. D., Mann, C. M., Markham, J. L., Bell, H. C., Gustafson, J. E., Warmington, J. R., & Wyllie, S. G. (2001) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.00943.x · Cited by 1,117 · cited 1×
“Few essential oil components, such as terpene-4-ol terpenol isomers, inhibit cellular respiration and render the cell membrane ineffective as a permeable barrier [130, 131].”
In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils
Cosentino, S., Tuberoso, C. I. G., Pisano, B., Satta, M., Mascia, V., Arzedi, E., & Palmas, F. (1999) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.1999.00605.x · Cited by 1,055 · cited 1×
“Essential oils have a wide spectrum of inhibitory actions against many bacterial pathogens [127], since theymay readily enter the lipid component of the bacterial cell membrane and break the cell wall structure [128].”
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051 · cited 1×
“However, resistance to carbapenem may take place due to the accumulation of carbapenemases like IMP, associated oxacillinases (OXA), and carbapenemases [39].”
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.003 · Cited by 1,038 · cited 1×
“It has been observed that a rise in the number of MDR is resulting in the nonavailability of any alternate to treat such strains, which henceforth is responsible for the high incidence of morbidity and mortality [50].”
In vitro antibacterial activity of some plant essential oils
Prabuseenivasan, S., Jayakumar, M., & Ignacimuthu, S. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-39 · Cited by 1,030
Action and resistance mechanisms of antibiotics: A guide for clinicians
Kapoor, G., Saigal, S., & Elongavan, A. (2017) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_349_15 · Cited by 1,022 · cited 10×
“Gram-positive bacterium that attained special genes that are present in the plasmid (extra chromosomal DNA), which were classi fi ed into 6 of the 19 families and transposons like Tn1547 that provide resistance to vancomycin [74].”
InfluentialLee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016 · cited 2×
“…resistance nodulation division (RND) superfamily, major facilitator superfamily (MFS), and small multidrug resistance (SMR) family transporters [95] (iii) The three types of enzymes present, acetyltransfer-ases, adenyltransferases, and phosphotransferases, are important in mediating A .…”
Zhang, Y., Liu, X., Wang, Y., Jiang, P., & Quek, S. (2016) · Food Control · doi:10.1016/j.foodcont.2015.05.032 · Cited by 941
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897 · cited 1×
“PBP2a, with a less affinity for all β-lactam [164].”
Antibacterial coatings on titanium implants
Zhao, L., Chu, P. K., Zhang, Y., & Wu, Z. (2009) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.31463 · Cited by 866 · cited 1×
“The absence of erythrocyte hemolysis indicates that conjugating synthetic peptides with nanocarriers reduces host cytotoxicity [117].”
Rizzello, L., & Pompa, P. P. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60218d · Cited by 822 · cited 1×
“Organic and inorganic nano-ordered surfaces and coatings are now the most popular alternatives for preventing bio fi lm growth on medical devices [121].”
Munoz-Price, L. S., & Weinstein, R. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra070741 · Cited by 772 · cited 1×
“baumannii is a Gram-negative bacillus that causes infections in hospitals and intensive care units [36].”
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions
Cox, G., & Wright, G. D. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.009 · Cited by 697 · cited 1×
“To escape from the harmful e ff ects of antibiotics, certain bacterial species develop some special mechanisms like e ffl ux pumps, less permeability of the LPS layer, secretion of degrading enzymes, and alteration of targets [2].”
Textbook of Diagnostic Microbiology
Mahon, E. B. C. R., Lehman, D. C., & Manuselis, G. (1997) · Cited by 660
Understanding the pathway of antibacterial activity of copper oxide nanoparticles
Meghana, S., Kabra, P., Chakraborty, S., & Padmavathy, N. (2015) · RSC Advances · doi:10.1039/c4ra12163e · Cited by 626
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Pachori, P., Gothalwal, R., & Gandhi, P. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.04.001 · Cited by 620 · cited 2×
“Ceftazidime and cefepime, which belong to the third and fourth generations of cephalosporins, are two of the most e ff ective β -lactams for treating Pseudomonas aeruginosa [96]. β -lactamases break the amide link in the beta-lactam ring, rendering medicines ine ff ective.”
Toxicity Mechanisms in Escherichia coli Vary for Silver Nanoparticles and Differ from Ionic Silver
Ivask, A., ElBadawy, A., Kaweeteerawat, C., Boren, D., Fischer, H., Ji, Z., Chang, C. H., Liu, R., Tolaymat, T., Telesca, D., et al. (2014) · ACS Nano · doi:10.1021/nn4044047 · Cited by 599
Multidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns
Ko, W.-C., Paterson, D. L., Sagnimeni, A. J., Hansen, D. S., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0802.010025 · Cited by 566
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556 · cited 1×
“Certain medical devices, like endotracheal tubes, urinary catheters, vascular lines, and feeding tubes, are also recognized as high-risk factors [13].”
Simon-Deckers, A., Loo, S., Mayne-L’hermite, M., Herlin-Boime, N., Menguy, N., Reynaud, C., Gouget, B., & Carrière, M. (2009) · Environmental Science & Technology · doi:10.1021/es9016975 · Cited by 546
Essential Oils: Sources of Antimicrobials and Food Preservatives
Pandey, A. K., Kumar, P., Singh, P., Tripathi, N. N., & Bajpai, V. K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02161 · Cited by 508 · cited 1×
“Many plants’ essential oils are utilized in aromatherapy, food flavoring and additives, cosmetics, polymers and resins, and perfumes [126].”
Chemical composition and antibacterial and antioxidant properties of commercial essential oils
Teixeira, B., Marques, A., Ramos, C., Neng, N. R., Nogueira, J. M. F., Saraiva, J. A., & Nunes, M. L. (2013) · Industrial Crops and Products · doi:10.1016/j.indcrop.2012.07.069 · Cited by 498 · cited 1×
“Essentialoils have a wide spectrum of inhibitory actions against many bacterial pathogens [127], since they may readily enter the lipid component of the bacterial cell membrane and break the cell wall structure [128].”
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490 · cited 1×
“A nonenzymatic pathway for fl uoroquinolone resistance among Enterobacteriaceae was also observed, such as a plasmid-borne quinolone resistance gene [93].”
Zhou, Y., Kong, Y., Kundu, S., Cirillo, J. D., & Liang, H. (2012) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-10-19 · Cited by 486
Nonribosomal peptide synthetases: structures and dynamics
Strieker, M., Tanović, A., & Marahiel, M. A. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.01.009 · Cited by 441 · cited 1×
“NRAPs are a subclass of nonribosomal peptides that are produced by gigantic non-ribosomal peptide synthetases (NRPSs) [151].”
Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?
Exner, M., Bhattacharya, S., Christiansen, B., Gebel, J., Goroncy‐Bermes, P., Hartemann, P., Heeg, P., Ilschner, C., Krämer, A., Larson, E., et al. (2017) · PubMed · doi:10.3205/dgkh000290 · Cited by 429 · cited 1×
“Gram-negative bacteria become more antibiotic resistant than Gram-positive bacteria because Gram-positive bacteria lack this layer [90, 91].”
Methicillin Resistance in Staphylococcus Aureus: Mechanisms and Modulation
Stapleton, P. D., & Taylor, P. W. (2002) · Science Progress · doi:10.3184/003685002783238870 · Cited by 416 · cited 1×
“Klebsiella pneumonia and Staphylococcus aureus are found to be resistant to linezolid, and this is achieved by the mutation in allele which encodes the 23 s rRNA ribosomal subunit [162].”
Epstein, L., Hunter, J. C., Arwady, M. A., Tsai, V., Stein, L., Gribogiannis, M., Frias, M., Guh, A. Y., Laufer, A. S., Black, S., et al. (2014) · JAMA · doi:10.1001/jama.2014.12720 · Cited by 400
Nanoparticle-based local antimicrobial drug delivery
Gao, W., Chen, Y., Zhang, Y., Zhang, Q., & Zhang, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.015 · Cited by 396 · cited 1×
“Antimicrobial agents that are unstable, such as bacteriophages, phytochemicals, peptides, and antibiotics, can be delivered by utilizing both organic and inorganic materials, such as chitosan and gold nanocarrier systems and drug nanovectors [111].”
Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches
Jubeh, B., Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25122888 · Cited by 383 · cited 4×
“Among such deadly pathogens, β -lactamase-resistant Streptococcus pneumonia , methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus faecium (VRE) are major Gram-positive bacteria associated with multidrug resistance and posing a serious threat to society [1, 52].”
InfluentialAntimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318535 · Cited by 369
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Pantosti, A., Sanchini, A., & Monaco, M. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.323 · Cited by 348
Paterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 344 · cited 1×
“aeruginosa are moist places and can be found mostly in washing sinks, aerators, equipment like respiratory gear, and unhygienic solutions in the hospital environment [20].”
Crisóstomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., & de Lencastre, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161272898 · Cited by 322
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320 · cited 1×
“Resistance to quinolones develops due to the mutations occurring in the subunits of these two enzymes (grIA/grIB and gyrA/gyrB) [60, 61]”
Klare, I., BADSTÜBNER, D., Konstabel, C., BÖHME, G., Claus, H., & Witte, W. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.45 · Cited by 304
Li, W., Sun, G., Yu, Y., Li, N., Chen, M., Jin, R., Jiao, Y., & Wu, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit675 · Cited by 304 · cited 1×
“Such bacterial strains are mostly susceptible to a variety of antibiotics; community-onset ESBL-secreting strains are becoming more common [35].”
Staying in Shape: the Impact of Cell Shape on Bacterial Survival in Diverse Environments
Yang, D. C., Blair, K. M., & Salama, N. R. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-15 · Cited by 295 · cited 1×
“It is well-known that Gram-positive bacteria have mainly two basic morphologic forms, like cocci (e.g., Staphylococcus ) and bacilli (e.g., Bacillus ) [54].”
Envelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_5021 · Cited by 292
Kim, L., McGee, L., Tomczyk, S., & Beall, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-15 · Cited by 285 · cited 1×
“Antibiotic resistance was also discovered against fluoroquinolones, tetracyclines, and chloramphenicol [79, 80].”
Sieradzki, K., & Tomasz, A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2557-2566.1997 · Cited by 274
Recent advances in engineering nonribosomal peptide assembly lines
Winn, M., Fyans, J. K., Zhuo, Y., & Micklefield, J. (2016) · Natural Product Reports · doi:10.1039/c5np00099h · Cited by 266 · cited 1×
“The NRPSs are made up of several modular sections, each of which is in charge of fusing amino acids into peptide-like products 10 BioMed Research International [152, 153].”
Miller, S. I. (2016) · mBio · doi:10.1128/mbio.01541-16 · Cited by 260 · cited 1×
“Gram-negative bacteria become more antibiotic resistant than Gram-positive bacteria because Gram-positive bacteria lack this layer [90, 91].”
Cui, L., Iwamoto, A., Lian, J.-Q., Neoh, H.-M., Maruyama, T., Horikawa, Y., & Hiramatsu, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.428-438.2006 · Cited by 240 · cited 1×
“Vancomycin kills the bacterial cell by breaking the PPCB (pentapeptide cross bridge) bond between two NAM units (D-Ala-D-Ala residues) [70, 71].”
Sotelo-Boyás, M. E., Correa-Pacheco, Z. N., Bautista-Baños, S., & Corona-Rangel, M. L. (2017) · LWT · doi:10.1016/j.lwt.2016.11.022 · Cited by 238 · cited 1×
“As nanoemulsions, lime essential oils encapsulated with chitosan showed enhanced antibacterial activity against S. aureus , L. monocytogenes , Shigilla dysenterias , and E. coli [143, 144].”
Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 227
Li, H., Chen, Q., Zhao, J., & Urmila, K. (2015) · Scientific Reports · doi:10.1038/srep11033 · Cited by 213
Jamil, B., Abbasi, R., Abbasi, S., Imran, M., Khan, S. U., Ihsan, A., Javed, S., Bokhari, H., & Imran, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01580 · Cited by 208 · cited 1×
“coli [149], and Siparuna guianensis with chitosan as nanoencapsulation against Aedes aegypti as nanoencapsulation [150].”
Discovery of MRSA active antibiotics using primary sequence from the human microbiome
Chu, J., Vila-Farres, X., Inoyama, D., Ternei, M., Cohen, L. J., Gordon, E. A., Reddy, B. V. B., Charlop-Powers, Z., Zebroski, H. A., Gallardo-Macias, R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2207 · Cited by 206 · cited 1×
“Humimycin was also created via solid phase peptide synthesis, which is based on the investigation of the human microbiome using bioinformatics techniques and has a novel antibacterial action that targets lipid II lipase in MRSA and other bacteria [156].”
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., & Falagas, M. E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.028 · Cited by 202 · cited 1×
“It has been observed that patients infected with MDR strains of bacteria have more severe consequences than patients infected with other vulnerable organisms [5, 6].”
Coico, R. (2006) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mca03cs00 · Cited by 196
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways
Hassett, D. J., Sutton, M. D., Schurr, M. J., Herr, A. B., Caldwell, C. C., & Matu, J. O. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.12.003 · Cited by 196 · cited 1×
“Moreover, fewer patients have experienced the chronic biofilmassociated pseudomonal establishment along with cystic fibrosis (CF) [21].”
Panáček, A., Smékalová, M., Kilianová, M., Prucek, R., Bogdanová, K., Večeřová, R., Kolář, M., Havrdová, M., Płaza, G. A., Chojniak, J., et al. (2015) · Molecules · doi:10.3390/molecules21010026 · Cited by 192 · cited 1×
“When nanoparticles are conjugated to therapeutic drugs like antibiotics, a synergistic antibacterial effect may be obtained; they can also create nanocarrier antimicrobial complexes with bactericide properties [110].”
Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future
Lee, T., Pang, S., Abraham, S., & Coombs, G. W. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.08.016 · Cited by 190 · cited 1×
“faecium is a Gram-positive bacterium that attained special genes that are present in the plasmid (extra chromosomal DNA), which were classified into 6 of the 19 families and transposons like Tn1547 that provide resistance to vancomycin [74].”
Differential Staining of Bacteria: Gram Stain
Moyes, R. B., Reynolds, J., & Breakwell, D. P. (2009) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mca03cs15 · Cited by 189 · cited 2×
“The change in cell wall composition between two species of bacteria is the cause of this discrepancy [87, 88].”
The Interaction of Bacteria with Engineered Nanostructured Polymeric Materials: A Review
Armentano, I., Arciola, C. R., Fortunati, E., Ferrari, D., Mattioli, S., Amoroso, C. F., Rizzo, J., Kenny, J. M., Imbriani, M., & Visai, L. (2014) · The Scientific World Journal · doi:10.1155/2014/410423 · Cited by 188
Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
Perez, F., & Van Duin, D. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12182 · Cited by 184 · cited 1×
“As a result, this increase in the spread of antibacterial resistance leads to posing a serious threat to society as well as to the medicines available and also causes a negative impact on cancer therapy, transplantation, and surgical events [7].”
Zhang, J., Ye, K.-P., Zhang, X., Pan, D.-D., Sun, Y.-Y., & Cao, J.-X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02094 · Cited by 182 · cited 1×
“The amount of bioactive components found in various essential oils, for example, has a signi fi cant and unique function; essential oils isolated from cinnamon and black pepper, for example, damage cell membranes and inhibit E. coli and S. aureus metabolic activity [132, 133].”
Insights into the chemical logic and enzymatic machinery of NRPS assembly lines
Walsh, C. T. (2016) · Natural Product Reports · doi:10.1039/c5np00035a · Cited by 181
The antimicrobial resistance profile of Streptococcus pneumoniae
Reinert, R. R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02724.x · Cited by 179
Community-acquired Acinetobacter infections
Falagas, M. E., Karveli, E. A., Kelesidis, I., & Kelesidis, T. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0365-6 · Cited by 177 · cited 3×
“Moreover, in Asia and Australia, the community associated with A. baumannii illness has been well-recognized [37].”
InfluentialMorin, C. A., & Hadler, J. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/323459 · Cited by 172
Fluoroquinolone resistance in Salmonella: insights by whole-genome sequencing
Cuypers, W. L., Jacobs, J., Wong, V., Klemm, E. J., Deborggraeve, S., & Van Puyvelde, S. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000195 · Cited by 171 · cited 1×
“Another method worth mentioning is plasmid-mediated quinolone resistance (PMQR), where physical protection is supplied by genes like Qnr, the Aac-60-lbcr gene reduces FQ action, and quinolone e ffl ux pumps are encoded by oqxAB and qepA [99].”
Thurlow, L. R., Joshi, G. S., & Richardson, A. R. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00937.x · Cited by 166 · cited 1×
“It has been observed that this USA300 strain is distinguished by the existence of staphylococcal cassette chromosome mec (SCCmec) type IV along with the genes responsible for the secretion of Panton-Valentine leucocidin (PVL) toxins [19].”
Eveillard, M., Kempf, M., Belmonte, O., Pailhoriès, H., & Joly-Guillou, M.-L. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.03.021 · Cited by 161 · cited 1×
“In addition to this, A. baumannii has also been isolated from human lice [38].”
Identification of New Delhi Metallo-β-lactamase 1 in Acinetobacter lwoffii of Food Animal Origin
Wang, Y., Wu, C., Zhang, Q., Qi, J., Liu, H., Wang, Y., He, T., Ma, L., Lai, J., Shen, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037152 · Cited by 155
Evolving Resistance Among Gram-positive Pathogens
Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 154 · cited 1×
“…enzymatic breakdown of antibiotics (ii) By reducing the a ffi nity and susceptibility of their target site, e.g., PBP (penicillin-binding protein), through either attainment of exogenous DNA or through mutation among native PBP genes [56, 57] Di ff erent antibiotics have diverse mechanisms of action.”
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat
Lutgring, J. D. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.011 · Cited by 152 · cited 1×
“are among the Enterobacteriaceae species with inherent imipenem resistance [94] 5.”
Next-generation precision antimicrobials: towards personalized treatment of infectious diseases
de la Fuente‐Núñez, C., Torres, M. D. T., Mojica, F. J. M., & Lu, T. K. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.014 · Cited by 148
S-carvone as a natural potato sprout inhibiting, fungistatic and bacteristatic compound
Oosterhaven, K., Poolman, B., & Smid, E. J. (1995) · Industrial Crops and Products · doi:10.1016/0926-6690(95)00007-y · Cited by 146 · cited 1×
“Few essential oil components, such as terpene-4-ol terpenol isomers, inhibit cellular respiration and render the cell membrane ineffective as a permeable barrier [130, 131].”
Bloodstream Infections in Community Hospitals in the 21st Century: A Multicenter Cohort Study
Anderson, D. J., Moehring, R. W., Sloane, R. J., Schmader, K. E., Weber, D. J., Fowler, V. G., Smathers, E. C., & Sexton, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091713 · Cited by 143 · cited 1×
“aeruginosa are found to be uncommon [22, 23].”
Ruimy, R., Angebault, C., Djossou, F., Dupont, C., Epelboin, L., Jarraud, S., Lefevre, L. A., Bes, M., Lixandru, B. E., Bertine, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655901 · Cited by 143
RND Efflux Pumps: Structural Information Translated into Function and Inhibition Mechanisms
Ruggerone, P., Murakami, S., M. Pos, K., & Vargiu, A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660220 · Cited by 140 · cited 1×
“gene which specifically encodes the outer membrane porin protein, and this results in the change in OMPK36 variant porin which shows less permeability for the antibiotics in Klebsiella pneumonia [159].”
Naseri, M., Golmohammadzadeh, S., Arouiee, H., Jaafari, M. R., & Neamati, H. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7824 · Cited by 138
Resistance mechanisms of Gram-positive bacteria
Berger‐Bächi, B. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00185 · Cited by 136 · cited 1×
“…enzymatic breakdown of antibiotics (ii) By reducing the a ffi nity and susceptibility of their target site, e.g., PBP (penicillin-binding protein), through either attainment of exogenous DNA or through mutation among native PBP genes [56, 57] Di ff erent antibiotics have diverse mechanisms of action.”
Antibiotic resistance inEnterococcus faeciumclinical isolates
Cattoir, V., & Giárd, J.-C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.870886 · Cited by 135 · cited 1×
“faecium also reflects resistance to quinupristin–dalfopristin (a streptogramin drug) that inhibits bacterial protein synthesis through binding to 23-S rRNA of the 50S ribosomal subunit and stops its function [76].”
Sarıkürkçü, C., Tepe, B., Daferera, D. J., Polissiou, M. G., & Harmandar, M. (2007) · Bioresource Technology · doi:10.1016/j.biortech.2007.08.058 · Cited by 133
Potent Antibacterial Nanoparticles for Pathogenic Bacteria
Lai, H.-Z., Chen, W., Wu, C., & Chen, Y. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am507919m · Cited by 132
Rodríguez‐Baño, J., López-Prieto, M. D., Portillo, M. M., Retamar, P., Natera, C., Nuño, E., Herrero, M., del Arco, A., Muñoz, Á., Téllez, F., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03089.x · Cited by 132
Fontana, R., Aldegheri, M., Ligozzi, M., López, H. M., Sucari, A., & Satta, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.1980 · Cited by 125 · cited 1×
“Furthermore, other mechanisms are found to be associated with the resistance to cephalosporins as they undergo similar types of response regulator, CroR, serine/threonine kinase designated IreK, and phosphatase IreP [72, 73].”
Guleria, S., Tiku, A. K., Koul, A., Gupta, S., Singh, G., & Razdan, V. K. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/790580 · Cited by 124
Self-citationInducible expression eliminates the fitness cost of vancomycin resistance in enterococci
Foucault, M.-L., Depardieu, F., Courvalin, P. M., & Grillot‐Courvalin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006855107 · Cited by 121 · cited 1×
“In terms of inducible resistance, the fitness costs of VRE for Enterococci were found to be almost nothing [30, 31].”
Glycopeptide Resistance in Gram-Positive Cocci: A Review
Sujatha, S., & Praharaj, I. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/781679 · Cited by 120
Complete wetting of graphene by biological lipids
Luan, B., Huynh, T., & Zhou, R. (2016) · Nanoscale · doi:10.1039/c6nr00202a · Cited by 120 · cited 1×
“In addition, nanoparticles can harm the bacterial cell wall in a variety of ways, including electrostatic attraction, Van der Waals forces, and hydrophobic interactions [140 – 142].”
Assembly and clustering of natural antibiotics guides target identification
Johnston, C. W., Skinnider, M. A., Dejong, C. A., Rees, P. N., Chen, G. M., Walker, C., French, S., Brown, E. D., Bérdy, J., Liu, D. Y., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2018 · Cited by 111 · cited 1×
“These are frequently used, publicly accessible algorithms for predicting genetically encoded NRPs, such as PRISM, which predicted a cyclic telomycin derived from Streptomyces canus by mining biosynthetic scaffolds and characterized it with a novel antibacterial action by targeting cardiolipin [155].”
Bolukaoto, J. Y., Monyama, M. C., Chukwu, M. O., Lekala, S. M., Nchabeleng, M., Maloba, M. R. B., Mavenyengwa, R. T., Lebelo, S. L., Monokoane, S., Tshepuwane, C., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1328-0 · Cited by 110 · cited 3×
“linB genes are responsible for inhibiting the ribosomal translocation that develops clindamycin resistance in GBS [86].”
InfluentialDweba, C. C., Zishiri, O. T., & Zowalaty, M. E. E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s175967 · Cited by 107 · cited 2×
“Resistance develops as a result of the production of extra penicillin-binding proteins like PBP2a, which reduces the affinity for penicillin and β-lactam antibiotics [65, 68, 69].”
Lavigne, J., Sotto, A., Nicolas-Chanoine, M.-H., Bouziges, N., Pagès, J., & Davin‐Regli, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.010 · Cited by 106 · cited 1×
“As discussed earlier, the WHO has drafted a list of such MDR and classi fi es them on the basis of severity of infection as medium, high, and critical antibiotic-resistant bacteria [51].”
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Witte, W. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03097.x · Cited by 103 · cited 1×
“However, the epidemiology of such CA-MRSA (community-associated methicillin-resistant S. aureus ) has already been extensively evaluated [17, 18].”
Enhanced biomimic bactericidal surfaces by coating with positively-charged ZIF nano-dagger arrays
Yuan, Y., & Zhang, Y. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.06.003 · Cited by 103 · cited 1×
“The experiments of [122, 123] show that zeolitic imidazolate framework (ZIF), nanodragger arrays, and nanostructured polyurethane can prevent the formation of Staphylococcus epidermis , S. aureus , E. coli , and P. mirabilis bio fi lms by allowing bacterial cells to adhere to the topography of the…”
Ferreira, T. P., Haddi, K., Corrêa, R. F. T., Zapata, V. L. B., Piau, T. B., de Souza, L. F. N., Santos, S.-M. G., de Oliveira, E. E., Jumbo, L. O. V., Ribeiro, B. M., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007624 · Cited by 102
Li, B., Jiang, B., Boyce, B. M., & Lindsey, B. A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.042 · Cited by 102
A systematic review: the current status of carbapenem resistance in East Africa
Ssekatawa, K., Byarugaba, D. K., Wampande, E., & Ejobi, F. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3738-2 · Cited by 93 · cited 1×
“Resistance to the several other group of drugs such as penicillin, pleuromutilins, lincosamides, and oxazolidons can be achieved with the help of enzyme chloramphenicol fl orfenicol resistance methyltransferase through the incorporation of CH 3 to A2503 in the 23s rRNA [163].”
Antimutagenic and antioxidant activity of the essential oils of Citrus sinensis and Citrus latifolia
Toscano-Garibay, J. D., Arriaga‐Alba, M., Sánchez-Navarrete, J., Mendoza-García, M., Flores‐Estrada, J., Moreno‐Eutímio, M. A., Espinosa-Aguirre, J. J., González‐Ávila, M., & Ruiz-Pérez, N. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-11818-5 · Cited by 93
Jemaa, M. B., Neves, M. A., Falleh, H., Isoda, H., Ksouri, R., & Nakajima, M. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.01.062 · Cited by 92 · cited 1×
“coli [148], chitosan with cardamom essential oil as nanocomposites against S.”
Nanoencapsulated Thymus capitatus essential oil as natural preservative
Jemaa, M. B., Falleh, H., Serairi, R., Neves, M. A., Snoussi, M., Isoda, H., Nakajima, M., & Ksouri, R. (2017) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2017.08.017 · Cited by 90 · cited 1×
“As nanoemulsions, lime essential oils encapsulated with chitosan showed enhanced antibacterial activity against S. aureus , L. monocytogenes , Shigilla dysenterias , and E. coli [143, 144].”
Fighting infections due to multidrug-resistant Gram-positive pathogens
Cornaglia, G. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02737.x · Cited by 87 · cited 1×
“Among such deadly pathogens, β -lactamase-resistant Streptococcus pneumonia , methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus faecium (VRE) are major Gram-positive bacteria associated with multidrug resistance and posing a serious threat to society [1, 52].”
β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis
Fisher, J. F., & Mobashery, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025221 · Cited by 86
Drug-resistant Streptococcus pneumoniae: rational antibiotic choices
Jacobs, M. R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00351-9 · Cited by 84 · cited 1×
“Children and daycare workers are more prone to this resistant Pneumococci infection [77, 78].”
Billal, D. S., Feng, J., Leprohon, P., Légaré, D., & Ouellette, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-512 · Cited by 81 · cited 1×
“Because of the downregulation of the main porin protein or re fi lling the cell membrane with some another selected protein channel, the permeability of membrane for antibiotics in some bacteria such as E. coli and Acinetobacter is decreased [160].”
Macrolide resistance mechanisms in Gram-positive cocci
Pechère, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00407-1 · Cited by 81 · cited 1×
“Resistance developed as a result of various mechanisms such as mutations in the 23S rRNA and protein L4, methylation of the 23S rRNA, and efflux systems Mef (A) and Msr (A) [57, 63]”
Asgarali, A., Stubbs, K. A., Oliver, A., Vocadlo, D. J., & Mark, B. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-08 · Cited by 79 · cited 1×
“The antibiotic combinatorial method is thus one of the most promising strategies for limiting antimicrobial resistance [108].”
Kujur, A., Kiran, S., Dubey, N. K., & Prakash, B. (2017) · LWT · doi:10.1016/j.lwt.2017.07.054 · Cited by 77 · cited 1×
“Aspergillus parasiticus and Schinus Moller use chitosan [145, 146], lipid phase, and orecirol as solid lipid nanoparticles against Aspergillus flavus, Aspergillus niger, Aspergillus ochraceus, Alternaria solani, Rhizopus stolonifer, and Rhizoctonia solani [147].”
Pannaraj, P. S., Bard, J. D., Cerini, C., & Weissman, S. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000471 · Cited by 75 · cited 1×
“Moreover, much research data is available on carbapenemase-producing E. coli ST131 [47].”
Luque-Alcaraz, A. G., Cortez‐Rocha, M. O., Velázquez, C. A., Acosta-Silva, A. L., Santacruz‐Ortega, H., Burgos‐Hernández, A., Argüelles-Monal, W. M., & Plascencia‐Jatomea, M. (2016) · Journal of Nanomaterials · doi:10.1155/2016/6060137 · Cited by 75
Vancomycin-Resistant Enterococci
Rubinstein, E., & Keynan, Y. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.006 · Cited by 73 · cited 1×
“Among them, the Van A gene cluster was discovered to be the most e ff ective and to be present on a transposon, i.e., linked to Tn1546 [75].”
Hussain, A., Ranjan, A. K., Nandanwar, N., Babbar, A., Jadhav, S., & Ahmed, N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03320-14 · Cited by 73
A 16-Year Prospective Study of Community-Onset Bacteremic Acinetobacter Pneumonia
Davis, J. S., McMillan, M., Swaminathan, A. D., Kelly, J. A., Piera, K., Baird, R., Currie, B. J., & Anstey, N. M. (2014) · CHEST Journal · doi:10.1378/chest.13-3065 · Cited by 72
Johnsen, P. J., Townsend, J. P., Bøhn, T., Simonsen, G. S., Sundsfjord, A., & Nielsen, K. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq512 · Cited by 67 · cited 1×
“In terms of inducible resistance, the fi tness costs of VRE for Enterococci were found to be almost nothing [30, 31].”
Hattemer, A., Hauser, A. R., Diaz, M. H., Scheetz, M. H., Shah, N. S., Allen, J. P., Porhomayon, J., & El-Solh, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02467-12 · Cited by 66 · cited 1×
“aeruginosa, 100% of isolates are meropenem susceptible, and 95% are susceptible to ceftazidime, tazobactam, and piperacillin [24].”
Impact of Gram-positive resistance on outcome of nosocomial pneumonia
Bodí, M. A., Ardanuy, C., & Rello, J. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104001-00005 · Cited by 60 · cited 1×
“It has been observed that patients infected with MDR strains of bacteria have more severe consequences than patients infected with other vulnerable organisms [5, 6].”
Khajuria, A., Praharaj, A. K., Kumar, M., & Grover, N. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7952.4413 · Cited by 59 · cited 7×
“It has become evident that avoparcin was not permitted for use in the USA or Canada, but it was widely used in Europe until 1997 [26].”
InfluentialAlves, T. F., Chaud, M. V., Grotto, D., Jozala, Â. F., Pandit, R., Rai, M., & dos Santos, C. A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0832-z · Cited by 59 · cited 1×
“…surface-modi fi ed gold nanoparticles and silver nanoparticles had a symbiotic repressive e ff ect of about 100% on Bacillus Calmette-Guerin and E. coli [113], while the silver nanoparticles conjugated with curcumin had a combined antimicrobial e ff ect on Pseudomonas aeruginosa and E. coli [114].”
Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci
Chun, S., Huh, H. J., & Lee, N. Y. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.2.205 · Cited by 59 · cited 1×
“viridans act as reservoirs for resistance genes like mef (E) and mel genes that show resistance to macrolide-lincosamidestreptogramin B (MLS (B)) antibiotics [83, 84].”
Multiple Roles of RNase Y in Streptococcus pyogenes mRNA Processing and Degradation
Chen, Z., Itzek, A., Malke, H., Ferretti, J. J., & Kreth, J. (2013) · Journal of Bacteriology · doi:10.1128/jb.00097-13 · Cited by 51 · cited 1×
“Moreover, it also reflects resistance to aminoglycosides, fluoroquinolones, and tetracyclines [85].”
Ssekatawa, K., Byarugaba, D. K., Kato, C. D., Ejobi, F., Tweyongyere, R., Lubwama, M., Kirabira, J. B., & Wampande, E. M. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-04817-7 · Cited by 50 · cited 1×
“It has been noticed that such resistance develops in bacteria due to genetic mutations and/or acquired genomes [49] (Table 1).”
Benyoucef, F., Dib, M. E. A., Arrar, Z., Costa, J., & Muselli, A. (2018) · Journal of Applied Biotechnology Reports · doi:10.29252/jabr.05.04.03 · Cited by 47
Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know
van Duin, D. (2017) · Virulence · doi:10.1080/21505594.2017.1306621 · Cited by 45
Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane
Hofmann, D., Messerschmidt, C., Bannwarth, M. B., Landfester, K., & Mailänder, V. (2013) · Chemical Communications · doi:10.1039/c3cc48130a · Cited by 43 · cited 1×
“Nanodelivery systems increase the vulnerability of MDR bacterial strains to specific antibiotics by protecting them from bacterial hydrolytic enzymes and suppressing resistance mechanisms such as changes in outer membrane porin proteins that result in antibiotic impermeability [109].”
Garcia‐Gonzalez, E., Müller, S., Ensle, P., Süßmuth, R. D., & Genersch, E. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12417 · Cited by 43
Jahnke, J. P., Cornejo, J. A., Sumner, J. J., Schuler, A. J., Atanassov, P. B., & Ista, L. K. (2016) · Biointerphases · doi:10.1116/1.4939244 · Cited by 40 · cited 1×
“[100 – 106].”
Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections
Wolfe, C. M., Cohen, B., & Larson, E. (2014) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2014.01.001 · Cited by 36
Asadishad, B., Hidalgo, G., & Tufenkji, N. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02622.x · Cited by 33
Bruinsma, N., Stobberingh, E. E., de Smet, P., & van den Bogaard, A. E. J. M. (2003) · Infection · doi:10.1007/s15010-002-3035-8 · Cited by 32 · cited 2×
“It has also become evident in the European study that such vancomycin-resistant Enterococci were isolated in the fecal material of healthy individuals [25].”
Manssouri, M., Znini, M., & Majidi, L. (2020) · Journal of Taibah University for Science · doi:10.1080/16583655.2019.1710394 · Cited by 28
Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.
Wang, E. E., Kellner, J. D., & Arnold, S. (1998) · PubMed · Cited by 25
Decreased bacteria density on nanostructured polyurethane
Yao, C., Webster, T. J., & Hedrick, M. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34856 · Cited by 23 · cited 1×
“The experiments of [122, 123] show that zeolitic imidazolate framework (ZIF), nanodragger arrays, and nanostructured polyurethane can prevent the formation of Staphylococcus epidermis , S. aureus , E. coli , and P. mirabilis bio fi lms by allowing bacterial cells to adhere to the topography of the…”
Poole, T. L., Hume, M. E., Campbell, L., Scott, H. M., Alali, W. Q., & Harvey, R. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4382-4385.2005 · Cited by 23 · cited 1×
“Afterwards, such VRE were collected from the wastewater from a semi-closed agri-food system [27].”
LEE, J. H., Jang, M., Seo, J., & Kim, G. (2011) · Journal of Food Safety · doi:10.1111/j.1745-4565.2010.00277.x · Cited by 20 · cited 1×
“Essential oils are natural substances made up of volatile secondary metabolites extracted from various parts of plants, including flowers, seeds, buds, twigs, leaves, barks, herbs, roots, and fruits [124, 125].”
Omotola, A. M., Li, Y., Martin, E. T., Alshabani, K., Yadav, D., Sarkar, M., Thapa, S. D., Kumar, V., Mahabashya, A., Ahmad, S. S., et al. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.05.025 · Cited by 17
Metadata
- Authors
- Bharadwaj, A., Rastogi, A., Pandey, S., Gupta, S., & Sohal, J. S.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2022-01
- Volume
- 2022
- Issue
- 1
- Pages
- 5419874-5419874
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W4294968734
- Cited by
- 213
- References
- 152
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.